EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Protein Tyrosine Phosphatases via PROteolysis-TArgeting Chimeras (PROTACs): Current Developments and Prospects

Rosanna Maccari iD

Molecules · 2025

DOI: 10.3390/molecules30224449 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Rosanna Maccari. Beteiligte Einrichtung: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d'Alcontres 31, 98166 Messina, …. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatases, Proteolysis Targeting Chimera, Drug Development, Enzyme Inhibitors. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein tyrosine phosphatases (PTPs) are prominent enzymes which play pivotal roles in the regulation of multifarious cellular functions. Dysregulations of several PTPs have well-documented implications in the pathogenesis of various human diseases, including diabetes, cancer, and neurodegenerative and inflammatory disorders. Therefore, PTPs are considered attractive targets for therapeutic intervention. However, the development of novel drugs targeting these enzymes has encountered several difficulties. Currently, it has become clear that improving PTP druggability can be an attainable goal, through different medicinal chemistry approaches. Besides the development of allosteric inhibitors of PTPs, the design of PROteolysis-TArgeting Chimeras (PROTACs) has emerged as a promising strategy capable of providing a useful alternative mechanism to control these enzymes through their targeted degradation. Although the development of PROTACs directed to PTPs is still in its infancy, the results so far available are promising; this perspective study focuses on this class of potential novel drugs, highlighting advantages and challenging aspects to consider for future progress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Tyrosine PhosphatasesProteolysis Targeting ChimeraDrug DevelopmentEnzyme InhibitorsMolecular Targeted TherapyProteolysisDrug DesignHumansAllosteric RegulationAllosteric Site

Stichwörter der Autor:innen

PROTACscancerdiabetesprotein tyrosine phosphatasestargeted protein degradation

Substanzen

Protein Tyrosine PhosphatasesProteolysis Targeting ChimeraEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d'Alcontres 31, 98166 Messina, Italy.

ORCID-Profile: Rosanna Maccari

Zitieren

APA

Maccari, R. (2025). Targeting Protein Tyrosine Phosphatases via PROteolysis-TArgeting Chimeras (PROTACs): Current Developments and Prospects. Molecules. https://doi.org/10.3390/molecules30224449

Vancouver

Maccari R. Targeting Protein Tyrosine Phosphatases via PROteolysis-TArgeting Chimeras (PROTACs): Current Developments and Prospects. Molecules. 2025. doi:10.3390/molecules30224449

BibTeX
@article{Maccari2025,
  author = {Maccari, Rosanna},
  title = {Targeting Protein Tyrosine Phosphatases via PROteolysis-TArgeting Chimeras (PROTACs): Current Developments and Prospects},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30224449}
}
Kostenlos starten →